Medicine and Dentistry
Patient
100%
Breast Cancer
96%
Patient with Cancer
33%
Malignant Neoplasm
33%
COVID-19
32%
Triple Negative Breast Cancer
31%
Neoplasm
28%
Tumor Infiltrating Lymphocyte
26%
Therapeutic Procedure
26%
Immunity
25%
Stromal Tumor
21%
Systemic Therapy
20%
Breast
19%
Analysis
16%
T Cell
15%
Hematologic Malignancy
12%
Hospital
12%
Cancer Cell
12%
Marker
11%
Vaccine
10%
Lymphoid Cell
10%
Lymph Node
10%
Puerperium
10%
Axillary Lymph Node
10%
Experience
10%
Pregnancy
10%
Distant Metastasis
10%
B Lymphocyte
10%
Cohort Analysis
10%
Tumour Heterogeneity
10%
Adjuvant Chemotherapy
10%
Lymph Node Metastasis
10%
Epidermal Growth Factor Receptor
10%
Antibody-Drug Conjugate
10%
Cancer Growth
10%
Cyclin-Dependent Kinase
10%
Clinical Trial
10%
Neoadjuvant Chemotherapy
9%
Diagnosis
8%
Tumor Microenvironment
8%
Biological Marker
8%
COVID-19 Vaccine
8%
Cancer Therapy
6%
Cancer
6%
Hormone Therapy
6%
Metastatic Carcinoma
6%
Axilla
6%
Adverse Event
5%
Cells
5%
Osteoclast Differentiation Factor
5%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
34%
Innate Lymphoid Cell
31%
B Cell
20%
COVID-19
15%
Allergy
12%
Vaccination
11%
Immune Tolerance
10%
Cytotoxic T-Cell
10%
T-Helper Cell
10%
Immunogenicity
10%
Neutrophil
10%
Immune Escape
10%
Inflammation
6%
CXCL13
6%
